Furthermore, a recent report has revealed that acetylated H2A.Z can generate new ectopic enhancers, resulting in aberrant gene transcriptional activation in androgen receptor (AR) dependent prostate cancer [120]. The gene discussed is AR; the disease is prostate carcinoma.